- Research works
- 80 ▲ 56% vs 2013–17
- Citations
- 447 5.6 per fractional work
- Top-10% rate
- 14.3% record average 16.5%
- Open access
- 59% world 28%
Not ranked overall: GenePath Dx (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.0×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Immunology and Microbiology 2.7×
- Medicine 2.1×
- Computer Science 1.8×
- Decision Sciences 1.5×
- Agricultural and Biological Sciences 1.2×
- Health Professions 1.1×
- Neuroscience 0.7×
- Environmental Science 0.6×
- Business, Management and Accounting 0.6×
- Engineering 0.5×
- Materials Science 0.4×
- Psychology 0.3×
- Physics and Astronomy 0.2×
- Mathematics 0.2×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
Which keywords describe research at GenePath Dx (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Deep Learning, Machine Learning, Vaccine, Epidemiology, Healthcare, Image Processing, Immune Response and Data Mining.
- Teratomas
- Immune Response
- Image Processing
- Healthcare
- Machine Learning
- Deep Learning
- Epidemiology
- Vaccine
- Data Mining
- Fetal Surgery
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 10 words, with their numbers
- Deep Learning3▲ 3.9×13 topics
- Machine Learning3▲ 4.0×12 topics
- Epidemiology2▲ 2.6×16 topics
- Healthcare2▲ 5.9×4 topics
- Vaccine1▲ 15×6 topics
- Image Processing1▲ 12×3 topics
- Data Mining1▲ 6.7×5 topics
- Immune Response1▲ 8.3×7 topics
- Fetal Surgery1▲ 82×1 topic
- Teratomas1▲ 423×1 topic
Which research topics does GenePath Dx (India) publish most on?
By volume in 2022–2025: Teratomas and Epidermoid Cysts, Biomedical and Engineering Education, Smart Agriculture and AI and RNA Interference and Gene Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Teratomas and Epidermoid Cysts Surgery 1 works
- 2 Biomedical and Engineering Education Biomedical Engineering 0 works
- 3 Smart Agriculture and AI Plant Science 0 works
- 4 RNA Interference and Gene Delivery Molecular Biology 0 works
- 5 Advanced MRI Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 6 Animal Virus Infections Studies Animal Science and Zoology 0 works
- 7 Cancer Genomics and Diagnostics Cancer Research 0 works
- 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 9 Reproductive System and Pregnancy Immunology 0 works
- 10 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GenePath Dx (India)'s research output changed?
Output in 2018–2022 was 56% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pune
- Savitribai Phule Pune University
- National Chemical Laboratory
- Symbiosis International University
- Bharati Vidyapeeth Deemed University
- Dr. D. Y. Patil Medical College, Hospital and Research Centre
- Tata Consultancy Services (India)
- Armed Forces Medical College
- International Institute of Information Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.